学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
DEVELOPMENT OF AN AUTOMATED CLOSED SYSTEM FOR GENERATION OF HUMAN LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS FOR USE IN ADOPTIVE IMMUNOTHERAPY
被引:49
作者
:
MUUL, LM
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, DEPT TRANSFUS MED, BETHESDA, MD 20892 USA
MUUL, LM
NASONBURCHENAL, K
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, DEPT TRANSFUS MED, BETHESDA, MD 20892 USA
NASONBURCHENAL, K
CARTER, CS
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, DEPT TRANSFUS MED, BETHESDA, MD 20892 USA
CARTER, CS
CULLIS, H
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, DEPT TRANSFUS MED, BETHESDA, MD 20892 USA
CULLIS, H
SLAVIN, D
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, DEPT TRANSFUS MED, BETHESDA, MD 20892 USA
SLAVIN, D
HYATT, C
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, DEPT TRANSFUS MED, BETHESDA, MD 20892 USA
HYATT, C
DIRECTOR, EP
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, DEPT TRANSFUS MED, BETHESDA, MD 20892 USA
DIRECTOR, EP
LEITMAN, SF
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, DEPT TRANSFUS MED, BETHESDA, MD 20892 USA
LEITMAN, SF
KLEIN, HG
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, DEPT TRANSFUS MED, BETHESDA, MD 20892 USA
KLEIN, HG
ROSENBERG, SA
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, DEPT TRANSFUS MED, BETHESDA, MD 20892 USA
ROSENBERG, SA
机构
:
[1]
NIH, DEPT TRANSFUS MED, BETHESDA, MD 20892 USA
[2]
FENWAL LABS, DEERFIELD, IL USA
来源
:
JOURNAL OF IMMUNOLOGICAL METHODS
|
1987年
/ 101卷
/ 02期
关键词
:
D O I
:
10.1016/0022-1759(87)90148-7
中图分类号
:
Q5 [生物化学];
学科分类号
:
071010 ;
081704 ;
摘要
:
引用
收藏
页码:171 / 181
页数:11
相关论文
共 9 条
[1]
LAFRENIERE R, 1985, CANCER RES, V45, P3735
[2]
MAZUMDER A, 1982, CANCER RES, V42, P913
[3]
MULE JJ, 1985, J IMMUNOL, V135, P646
[4]
ADOPTIVE IMMUNOTHERAPY OF ESTABLISHED PULMONARY METASTASES WITH LAK CELLS AND RECOMBINANT INTERLEUKIN-2
MULE, JJ
论文数:
0
引用数:
0
h-index:
0
MULE, JJ
SHU, SY
论文数:
0
引用数:
0
h-index:
0
SHU, SY
SCHWARZ, SL
论文数:
0
引用数:
0
h-index:
0
SCHWARZ, SL
ROSENBERG, SA
论文数:
0
引用数:
0
h-index:
0
ROSENBERG, SA
[J].
SCIENCE,
1984,
225
(4669)
: 1487
-
1489
[5]
MUUL LM, 1986, J IMMUNOL METHODS, V88, P265
[6]
AN ENZYMATIC METHOD FOR THE CONSISTENT PRODUCTION OF MONODISPERSED VIABLE CELL-SUSPENSIONS FROM HUMAN SOLID TUMORS
RONG, GH
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,SURG BRANCH,BETHESDA,MD 20205
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,SURG BRANCH,BETHESDA,MD 20205
RONG, GH
GRIMM, EA
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,SURG BRANCH,BETHESDA,MD 20205
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,SURG BRANCH,BETHESDA,MD 20205
GRIMM, EA
SINDELAR, WF
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,SURG BRANCH,BETHESDA,MD 20205
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,SURG BRANCH,BETHESDA,MD 20205
SINDELAR, WF
[J].
JOURNAL OF SURGICAL ONCOLOGY,
1985,
28
(02)
: 131
-
133
[7]
Rosenberg S A, 1986, Important Adv Oncol, P55
[8]
BIOLOGICAL-ACTIVITY OF RECOMBINANT HUMAN INTERLEUKIN-2 PRODUCED IN ESCHERICHIA-COLI
ROSENBERG, SA
论文数:
0
引用数:
0
h-index:
0
机构:
CETUS CORP, EMERYVILLE, CA 94608 USA
CETUS CORP, EMERYVILLE, CA 94608 USA
ROSENBERG, SA
GRIMM, EA
论文数:
0
引用数:
0
h-index:
0
机构:
CETUS CORP, EMERYVILLE, CA 94608 USA
CETUS CORP, EMERYVILLE, CA 94608 USA
GRIMM, EA
MCGROGAN, M
论文数:
0
引用数:
0
h-index:
0
机构:
CETUS CORP, EMERYVILLE, CA 94608 USA
CETUS CORP, EMERYVILLE, CA 94608 USA
MCGROGAN, M
DOYLE, M
论文数:
0
引用数:
0
h-index:
0
机构:
CETUS CORP, EMERYVILLE, CA 94608 USA
CETUS CORP, EMERYVILLE, CA 94608 USA
DOYLE, M
KAWASAKI, E
论文数:
0
引用数:
0
h-index:
0
机构:
CETUS CORP, EMERYVILLE, CA 94608 USA
CETUS CORP, EMERYVILLE, CA 94608 USA
KAWASAKI, E
KOTHS, K
论文数:
0
引用数:
0
h-index:
0
机构:
CETUS CORP, EMERYVILLE, CA 94608 USA
CETUS CORP, EMERYVILLE, CA 94608 USA
KOTHS, K
MARK, DF
论文数:
0
引用数:
0
h-index:
0
机构:
CETUS CORP, EMERYVILLE, CA 94608 USA
CETUS CORP, EMERYVILLE, CA 94608 USA
MARK, DF
[J].
SCIENCE,
1984,
223
(4643)
: 1412
-
1414
[9]
OBSERVATIONS ON THE SYSTEMIC ADMINISTRATION OF AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2 TO PATIENTS WITH METASTATIC CANCER
ROSENBERG, SA
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
ROSENBERG, SA
LOTZE, MT
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
LOTZE, MT
MUUL, LM
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
MUUL, LM
LEITMAN, S
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
LEITMAN, S
CHANG, AE
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
CHANG, AE
ETTINGHAUSEN, SE
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
ETTINGHAUSEN, SE
MATORY, YL
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
MATORY, YL
SKIBBER, JM
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
SKIBBER, JM
SHILONI, E
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
SHILONI, E
VETTO, JT
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
VETTO, JT
SEIPP, CA
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
SEIPP, CA
SIMPSON, C
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
SIMPSON, C
REICHERT, CM
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
REICHERT, CM
[J].
NEW ENGLAND JOURNAL OF MEDICINE,
1985,
313
(23)
: 1485
-
1492
←
1
→
共 9 条
[1]
LAFRENIERE R, 1985, CANCER RES, V45, P3735
[2]
MAZUMDER A, 1982, CANCER RES, V42, P913
[3]
MULE JJ, 1985, J IMMUNOL, V135, P646
[4]
ADOPTIVE IMMUNOTHERAPY OF ESTABLISHED PULMONARY METASTASES WITH LAK CELLS AND RECOMBINANT INTERLEUKIN-2
MULE, JJ
论文数:
0
引用数:
0
h-index:
0
MULE, JJ
SHU, SY
论文数:
0
引用数:
0
h-index:
0
SHU, SY
SCHWARZ, SL
论文数:
0
引用数:
0
h-index:
0
SCHWARZ, SL
ROSENBERG, SA
论文数:
0
引用数:
0
h-index:
0
ROSENBERG, SA
[J].
SCIENCE,
1984,
225
(4669)
: 1487
-
1489
[5]
MUUL LM, 1986, J IMMUNOL METHODS, V88, P265
[6]
AN ENZYMATIC METHOD FOR THE CONSISTENT PRODUCTION OF MONODISPERSED VIABLE CELL-SUSPENSIONS FROM HUMAN SOLID TUMORS
RONG, GH
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,SURG BRANCH,BETHESDA,MD 20205
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,SURG BRANCH,BETHESDA,MD 20205
RONG, GH
GRIMM, EA
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,SURG BRANCH,BETHESDA,MD 20205
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,SURG BRANCH,BETHESDA,MD 20205
GRIMM, EA
SINDELAR, WF
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,SURG BRANCH,BETHESDA,MD 20205
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,SURG BRANCH,BETHESDA,MD 20205
SINDELAR, WF
[J].
JOURNAL OF SURGICAL ONCOLOGY,
1985,
28
(02)
: 131
-
133
[7]
Rosenberg S A, 1986, Important Adv Oncol, P55
[8]
BIOLOGICAL-ACTIVITY OF RECOMBINANT HUMAN INTERLEUKIN-2 PRODUCED IN ESCHERICHIA-COLI
ROSENBERG, SA
论文数:
0
引用数:
0
h-index:
0
机构:
CETUS CORP, EMERYVILLE, CA 94608 USA
CETUS CORP, EMERYVILLE, CA 94608 USA
ROSENBERG, SA
GRIMM, EA
论文数:
0
引用数:
0
h-index:
0
机构:
CETUS CORP, EMERYVILLE, CA 94608 USA
CETUS CORP, EMERYVILLE, CA 94608 USA
GRIMM, EA
MCGROGAN, M
论文数:
0
引用数:
0
h-index:
0
机构:
CETUS CORP, EMERYVILLE, CA 94608 USA
CETUS CORP, EMERYVILLE, CA 94608 USA
MCGROGAN, M
DOYLE, M
论文数:
0
引用数:
0
h-index:
0
机构:
CETUS CORP, EMERYVILLE, CA 94608 USA
CETUS CORP, EMERYVILLE, CA 94608 USA
DOYLE, M
KAWASAKI, E
论文数:
0
引用数:
0
h-index:
0
机构:
CETUS CORP, EMERYVILLE, CA 94608 USA
CETUS CORP, EMERYVILLE, CA 94608 USA
KAWASAKI, E
KOTHS, K
论文数:
0
引用数:
0
h-index:
0
机构:
CETUS CORP, EMERYVILLE, CA 94608 USA
CETUS CORP, EMERYVILLE, CA 94608 USA
KOTHS, K
MARK, DF
论文数:
0
引用数:
0
h-index:
0
机构:
CETUS CORP, EMERYVILLE, CA 94608 USA
CETUS CORP, EMERYVILLE, CA 94608 USA
MARK, DF
[J].
SCIENCE,
1984,
223
(4643)
: 1412
-
1414
[9]
OBSERVATIONS ON THE SYSTEMIC ADMINISTRATION OF AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2 TO PATIENTS WITH METASTATIC CANCER
ROSENBERG, SA
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
ROSENBERG, SA
LOTZE, MT
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
LOTZE, MT
MUUL, LM
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
MUUL, LM
LEITMAN, S
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
LEITMAN, S
CHANG, AE
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
CHANG, AE
ETTINGHAUSEN, SE
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
ETTINGHAUSEN, SE
MATORY, YL
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
MATORY, YL
SKIBBER, JM
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
SKIBBER, JM
SHILONI, E
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
SHILONI, E
VETTO, JT
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
VETTO, JT
SEIPP, CA
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
SEIPP, CA
SIMPSON, C
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
SIMPSON, C
REICHERT, CM
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
REICHERT, CM
[J].
NEW ENGLAND JOURNAL OF MEDICINE,
1985,
313
(23)
: 1485
-
1492
←
1
→